TY  - RPRT
TI  - Design-space requirements for abundance-amplified drug-like targeting of RHSVV/PAb240-like p53 exposure in TP53-mutant cancer
AU  - Ishikawa, T.
PY  - 2026
DO  - 10.64898/2026.05.27.728141
UR  - https://www.biorxiv.org/content/10.64898/2026.05.27.728141v1
ID  - 10.64898/2026.05.27.728141
ER  -